Nagral Aabha, Poyekar Samriddhi, Sable Shailesh, Bagde Abhijit, Verma Rahul, Shah Ketul, Vasant Suresh, Sawant Ambreen, Mirza Darius
Department of Gastroenterology, Jaslok Hospital and Research Centre and Apollo Hospital, Mumbai, India.
Department of Liver Transplant Surgery, Jaslok Hospital and Research Centre, Mumbai, India.
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102589. doi: 10.1016/j.jceh.2025.102589. Epub 2025 May 14.
Budd-Chiari syndrome (BCS) in infants is rare, and there is limited published literature on liver transplantation (LT).
Eight children who underwent LT for BCS from 2017 to 2023 were analyzed.
Seven out of the eight children had radiological intervention (RI) prior to LT (3 had transjugular intrahepatic portosystemic shunt [TIPSS], and 4 had hepatic vein venoplasty). Hepatopulmonary syndrome (HPS) was seen post-TIPSS in 3 and postvenoplasty in 2 children, respectively. The indication for LT was refractory ascites or recurrent upper gastrointestinal bleed in 3 patients, HPS in 5 patients, respectively. The median age and weight of children at transplant was 51 months (IQR 26-82 months) and 11.35 kg (IQR 10.05-18 kg), respectively. The median duration from onset of symptoms to LT was 42 months (IQR 18.5-75 months). HPS resolved in the 4 patients alive, after a median period of 25 days (IQR 15.5-60 days). The median duration of post-transplant follow-up is 4 years 9 months (IQR 3 year 5 months-4 years 11 months). Vascular complications were seen in 37.5% patients which were amenable to RI. Biliary complications were seen in 25% of children. The 1-year and 3-year survival rates both were 75%.
BCS in infants can be managed effectively with RI followed by LT. LT has shown good long-term outcomes in children with BCS. HPS seems to be common after TIPSS in pediatric BCS. Recurrent BCS post-LT can be salvaged using RI. High biliary and vascular complications are likely related to HPS and previous TIPSS/RI.
婴儿布加综合征(BCS)较为罕见,关于肝移植(LT)的已发表文献有限。
分析了2017年至2023年期间因BCS接受LT的8名儿童。
8名儿童中有7名在LT前接受了放射介入(RI)(3例行经颈静脉肝内门体分流术[TIPSS],4例行肝静脉成形术)。分别有3名和2名儿童在TIPSS术后和静脉成形术后出现肝肺综合征(HPS)。LT的指征分别为3例患者的难治性腹水或反复上消化道出血,5例患者的HPS。移植时儿童的中位年龄和体重分别为51个月(四分位间距26 - 82个月)和11.35千克(四分位间距10.05 - 18千克)。从症状出现到LT的中位持续时间为42个月(四分位间距18.5 - 75个月)。4名存活患者的HPS在中位25天(四分位间距15.5 - 60天)后得到缓解。移植后随访的中位持续时间为4年9个月(四分位间距3年5个月 - 4年11个月)。37.5%的患者出现了可通过RI治疗的血管并发症。25%的儿童出现了胆道并发症。1年和3年生存率均为75%。
婴儿BCS可通过RI后行LT有效治疗。LT在BCS儿童中显示出良好的长期预后。小儿BCS中TIPSS术后HPS似乎较为常见。LT术后复发性BCS可通过RI挽救。高胆道和血管并发症可能与HPS及先前的TIPSS/RI有关。